Our finding suggested that the activation of AMPK decreased blood pressure, abolished ROS generation, and enhanced ERK1/2-RSK-nNOS pathway activity by negatively regulating Racl-induced NADPH oxidase levels in the RVLM during oxidative stress–associated hypertension. This evidence concerns the gene PRKAA1 and hypertensive disorder.